-
Study: Amylin's metreleptin improves diabetes, lipid control among patients
SAN DIEGO — An investigational drug improved diabetes and lipid control in patients with partial lipodystrophy, according to a new study.
Amylin Pharmaceuticals announced Saturday results of a study of metreleptin, an analog of the human hormone leptin. Results of the study were presented at the 93rd annual meeting and expo of the Endocrine Society in Boston.
-
Blog: Facebook inexpensive yet powerful marketing tool
ALBANY, N.Y. — The cost of acquiring a Facebook “liker?" Less than 13 cents per fan, according to a Media Logic blog entry posted last week. At least that’s what retailer Kirkland's spent in its pursuit of more than 200,000 Facebook surfers who opted-in on the Kirkland's page. And because the act of a Facebook user “liking” a page is posted on that person’s newsfeed, it fast becomes a case of “if you tell two friends and they each in turn tell two friends ...”